Accuracy of pathologic techniques for the diagnosis of metastatic melanoma in sentinel lymph nodes

Annals of Surgical Oncology

Volumn 6, Issue 7, 1999, Pages 699-704

  Gibbs, John F ^a   Huang, Peter P ^a   Zhang, Paul J ^a   Kraybill, William G ^a   Cheney, Richard ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Melanoma; Pathology; Sentinel node

Indexed keywords

ANTIBODY; EOSIN; HEMATOXYLIN; PROTEIN S 100; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER INVASION; DIAGNOSTIC ACCURACY; FEMALE; FROZEN SECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM PROTEINS; PREDICTIVE VALUE OF TESTS; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS;

EID: 0032699923     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
2. Albertini JJ, Cruse CW, Rapaport D, et al. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996;223:217-24.
3. Morton DL. Sentinel lymphadenectomy for patients with clinical stage I melanoma. J Surg Oncol 1997:66:267-9.
4. Thompson JF. Sentinel node biopsy. J Surg Oncol 1997;66:270-2.
5. Ross MI. Lymphatic mapping and sentinel node biopsy for early stage melanoma: How we do it at the M.D. Anderson Cancer Center. J Surg Oncol 1997;66:273-6.
6. Reintgen D. Lymphatic mapping and sentinel node harvest for malignant melanoma. J Surg Oncol 1997;66:277-81.
7. Karakousis CP, Najibi S, Trunk J. Sentinel node biopsy in malignant melanoma. J Surg Oncol 1997;66:282-4.
8. Emilia JCD, Lawrence W. Sentinel Lymph node biopsy in malignant melanoma: The standard of care? J Surg Oncol 1997;65: 153-4.
9. Kelly MC, Ollila DW, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for melanoma. Semin Surg Oncol 1998; 14:283-90.
10. Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998;16:2253-60.
11. Cochran AJ, Wen D-R, Morton DL. Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma: An immunohistological study. Am J Surg Pathol 1988;12: 612-8.
12. Urist MM, Maddox WA, Kennedy JE, Balch CM. Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients. Cancer 1983;51:2152-6.
13. Coit DG, Rogatko A, Brennan MF. Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes: A multivariate analysis. Ann Surg 1991;214:627-36.
14. Reintgen D. Melanoma nodal mets: Biologic significance and therapeutic considerations. Surg Oncol Clin N Am 1996;5:104-20.
15. Veronesi U, Adamus J, Bandiera DC, et al. Inefficacy of immediate node dissection in stage I melanoma of the limbs. N Engl J Med 1977;297:627-30.
16. Karakousis CP, Seddiq MK, Moore R. Prognostic value of lymph node dissection in malignant melanoma. Arch Surg 1980;115:719-22.
17. Milton GW, Shaw HM, McCarthy WH, Pearson L, Balch CM, Soong SJ Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients. Br J Surg 1982;69:108-11.
18. Balch CM. The role of elective lymph node dissection in melanoma: Rationale, results, and controversies. J Clin Oncol 1988;6: 163-72.
19. McCarthy WH, Shaw HM, Cascinelli N, Santinami M, Belli F. Elective lymph node dissection for melanoma: Two perspectives. World J Surg 1992;16:203-13.
20. Drepper H, Köhler CO, Bastian B, et al. Benefit of elective lymph node dissection in subgroups of melanoma patients. Cancer 1993; 72:741-9.
21. Coates AS, Ingvar CI, Petersen-Schaefer I, et al. Elective lymph node dissection in patients with primary melanoma of the trunk and limbs treated at the Sydney melanoma unit from 1960 to 1991. J Am Coll Surg 1995;180:402-9.
22. Balch CM, Soong SJ, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996;224:255-63.
23. Leong SPL. The role of sentinel lymph nodes in human solid cancer. PPO Updates 1998;12:1-12.
24. Joseph E, Brobeil A, Glass F, et al. Results of complete lymph node dissection in 83 patients with positive sentinel nodes. Ann Surg Oncol 1998;5:119-25.
25. Reintgen D, Cruse CW, Well K, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994;220:759-67.
26. Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. Interferon alpha-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Group Trail EST 1684. J Clin Oncol 1996;14:7-17.
27. Wagner JD, Davidson D, Coleman JJ, Hutchins G, Schauwecker D, Park H-M, Havlik RJ. Lymph node volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma. Ann Surg Oncol 1999;6:398-404.
28. Wang X, Heller R, VanVoorhis N, et al. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 1994;220:768-74.
29. Shivers SC, Wang W, Li W, et al. Molecular staging of malignant melanoma: Correlation with clinical outcome. JAMA 1998;280:1410-5.
30. Cho KH, Hashimoto K, Taniguchi Y, Pietruk T, Zarbo RJ, An T. Immunohistochemical study of melanocytic nevus and malignant melanoma with monoclonal antibodies against S-100 subunits. Cancer 1990;66:765-71.
31. Carson KF, Wen D-R, Li P-X, et al. Nodal nevi and cutaneous melanomas. Am J Surg Pathol 1996;20:834-40.